BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7866903)

  • 1. [Targeting treatment of human HCC xenografts implanted in nude mice using bifunctional antibody HC-1 combined with mitomycin C].
    Wei C; Tang ZY; Liu KD
    Zhonghua Yi Xue Za Zhi; 1994 Nov; 74(11):676-9, 709-10. PubMed ID: 7866903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Biodistribution of monoclonal antibody and Fab fragment and antitumor effect of their conjugates on hepatoma xenografts].
    Li J; Zhen Y; Yang Z
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1994 Oct; 16(5):328-33. PubMed ID: 7720121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Growth inhibition of human hepatocellular carcinoma xenograft in nude mice by combined treatment with human cytokine-induced killer cells and chemotherapy].
    Shi M; Yao L; Wang FS; Lei ZY; Zhang B; Li WL; Liu JC; Tang ZR; Zhou GD
    Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):465-8. PubMed ID: 15555334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Targeting therapy with adriamycin-monoclonal antibody (HAb18) conjugate in nude mice with human hepatocellular carcinoma xenografts].
    Sui Y
    Zhonghua Yi Xue Za Zhi; 1992 Jul; 72(7):397-400, 445. PubMed ID: 1330227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Application of radiolabeled anti-HBx monoclonal antibody for HCC targeting therapy].
    Li J; Tang Z; Liu K
    Zhonghua Yi Xue Za Zhi; 1996 Apr; 76(4):271-4. PubMed ID: 8758272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of immuno-drug conjugates on growth of human gastric cancer xenograft in subrenal capsule of nude mice].
    Zhang SY; Li S; Chen LJ; Shu YH; Zhang XY; Chen XT
    Zhongguo Yao Li Xue Bao; 1990 Nov; 11(6):556-60. PubMed ID: 2130622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Specific targeting of mitomycin C to tumors with the use of anti-gastric cancer monoclonal antibody].
    Li S
    Zhonghua Yi Xue Za Zhi; 1990 Jul; 70(7):363-6, 26. PubMed ID: 2171725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific targeting of mitomycin C to tumors by anti-gastric cancer monoclonal antibody.
    Li S; Zhang XY; Chen XT; Fan DM; Zhan SY; Chen LJ; Shu YH; Zhang JL
    Chin Med J (Engl); 1991 May; 104(5):358-62. PubMed ID: 1908761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of targeting treatment of mitomycin C immunoconjugate on stomach neoplasm].
    Chen LJ; Zhang SY; Zhang JL; Zhang Z; Li S; Chen M; Zhang XY; Chen XT
    Zhongguo Yao Li Xue Bao; 1993 Nov; 14(6):572-6. PubMed ID: 8010062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a human xenograft model for the evaluation of monoclonal antibody L6-mitomycin immunoconjugates.
    Trail PA; Rose WC
    In Vivo; 1989; 3(5):319-24. PubMed ID: 2519872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
    Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR
    Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental study of tumor directed therapy with gastric cancer monoclonal antibody-mitomycin conjugate combined with propranolol or angiotensin II].
    Zhou SQ; Wang NQ; Liu T; Dong ZW
    Yao Xue Xue Bao; 1992; 27(12):891-4. PubMed ID: 1299137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
    Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
    Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific targeting and killing activities of anti-P-glycoprotein monoclonal antibody MRK16 directed against intrinsically multidrug-resistant human colorectal carcinoma cell lines in the nude mouse model.
    Iwahashi T; Okochi E; Ariyoshi K; Watabe H; Amann E; Mori S; Tsuruo T; Ono K
    Cancer Res; 1993 Nov; 53(22):5475-82. PubMed ID: 8106147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine targeting in tumors using a bispecific antibody directed against carcinoembryonic antigen and tumor necrosis factor alpha.
    Robert B; Mach JP; Mani JC; Ychou M; Folli S; Artus JC; Pèlegrin A
    Cancer Res; 1996 Oct; 56(20):4758-65. PubMed ID: 8840995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-tumor activity of an anti-human alpha-fetoprotein antibody-human serum albumin-mitomycin C conjugate against human yolk sac tumor maintained in vitro and in nude mice in vivo].
    Ohkawa K; Tsukada Y; Umemoto N; Hara T
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):563-9. PubMed ID: 2420281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental study on targeting therapy of human hepatocellular carcinoma in nude mice using adriamycin-anti-transferrin receptor conjugate].
    Wang F; Li S; Lin J
    Zhonghua Zhong Liu Za Zhi; 1995 Sep; 17(5):354-7. PubMed ID: 8697974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose and long-term therapy with interferon-alfa inhibits tumor growth and recurrence in nude mice bearing human hepatocellular carcinoma xenografts with high metastatic potential.
    Wang L; Tang ZY; Qin LX; Wu XF; Sun HC; Xue Q; Ye SL
    Hepatology; 2000 Jul; 32(1):43-8. PubMed ID: 10869287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A human tumor xenograft model of therapy with a bispecific monoclonal antibody targeting c-erbB-2 and CD16.
    Weiner LM; Holmes M; Adams GP; LaCreta F; Watts P; Garcia de Palazzo I
    Cancer Res; 1993 Jan; 53(1):94-100. PubMed ID: 8093231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing bispecific antibody pretargeting for use in radioimmunotherapy.
    Sharkey RM; Karacay H; Richel H; McBride WJ; Rossi EA; Chang K; Yeldell D; Griffiths GL; Hansen HJ; Goldenberg DM
    Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3897S-913S. PubMed ID: 14506188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.